Literature DB >> 7549131

Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis.

N Kitami1, T Komada, H Ishii, H Shimizu, H Adachi, Y Yamaguchi, T Kitamura, H Oide, A Miyazaki, M Ishikawa.   

Abstract

We investigated the specificity of various autoantibodies in antimitochondrial antibody (AMA)-negative patients with primary biliary cirrhosis (PBC). We examined sera from 144 patients with PBC, 17 of whom were AMA negative by indirect immunofluorescence. The AMA-negative group showed a significantly higher positivity for smooth muscle antibody, but not for antinuclear antibody, as compared with the AMA-positive group. IgG class anti-PDH by enzyme-linked immunosorbent assay (ELISA) were detected in 13% of the AMA-negative group. However, all PBC patients showed positive IgG, IgA, and/or IgM class anti-M2 to the four M2 proteins by immunoblotting. These results suggest that the detection of IgG and IgM class anti-PDH and that of antibodies to the four M2 proteins increases the positivity of this ELISA method, and that detection of IgG, IgA, and IgM class anti-M2 to the four M2 proteins by immunoblotting is useful in diagnosing AMA-negative patients with PBC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549131     DOI: 10.2169/internalmedicine.34.496

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

1.  Autoimmune cholangitis.

Authors:  J Heathcote
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 2.  Enzyme inhibition assay for pyruvate dehydrogenase complex: clinical utility for the diagnosis of primary biliary cirrhosis.

Authors:  Katsuhisa Omagari; Hiroaki Hazama; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

Review 3.  Primary biliary cirrhosis with features of autoimmune hepatitis.

Authors:  J Heathcote
Journal:  Curr Gastroenterol Rep       Date:  2001-02

4.  Similar T-cell oligoclonality in antimitochondrial antibody-positive and -negative primary biliary cirrhosis.

Authors:  M J Mayo; P E Lipsky; S N Miller; P Stastny; B Combes
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

5.  Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis.

Authors:  Binu V John; Bassam Dahman; Yangyang Deng; Nidah S Khakoo; Tamar H Taddei; David E Kaplan; Cynthia Levy
Journal:  Liver Int       Date:  2021-10-12       Impact factor: 5.828

6.  Characterization of M2 antibodies in asymptomatic Chinese population.

Authors:  Xiao-Hua Jiang; Ren-Qian Zhong; Xiao-Yun Fan; Yin Hu; Feng An; Jian-Wen Sun; Xian-Tao Kong
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis.

Authors:  Xiao-Hua Jiang; Ren-Qian Zhong; Sheng-Qian Yu; Yin Hu; Weng-Weng Li; Xian-Tao Kong
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

8.  Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.

Authors:  Lina Feng; Kaihui Dong; Xiaoxue Zhang; Bo Ma; Lin Chen; Qianqian Yang; Qingling Chen; Xiaoyu Wen; Qinglong Jin
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

9.  Comparison of the clinical features of Japanese patients with primary biliary cirrhosis in 1999 and 2004: utilization of clinical data when patients applied to receive public financial aid.

Authors:  Fumio Sakauchi; Asae Oura; Hirofumi Ohnishi; Mitsuru Mori
Journal:  J Epidemiol       Date:  2007-11       Impact factor: 3.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.